Related Experiment Video
Updated: May 20, 2026

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
Recent progress in mucosal vaccine development: potential and limitations
1Center for Mucosal Immunobiology and Vaccines (MIVAC), Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Sweden. nils.lycke@microbio.gu.se
Abstract:
Most pathogens access the body through the mucosal membranes. Therefore, effective vaccines that protect at these sites are much needed. However, despite early success with the live attenuated oral polio vaccine over 50 years ago, only a few new mucosal vaccines have been subsequently launched. This is partly due to problems with developing safe and effective mucosal adjuvants. In the past decade, however, the successful development of live attenuated mucosal vaccines against influenza virus and rotavirus infections has boosted interest in this field, and great expectations for new mucosal vaccines lie ahead. Here, I discuss the expanding knowledge and strategies used in the development of mucosal vaccines.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Vaccinations
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Vaccines
Vaccine Production

